Citation Impact
Citing Papers
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Regulatory T cells in autoimmune kidney diseases and transplantation
2023 StandoutNobel
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
The Survival Benefit of Liver Transplantation
2005 Standout
A Meta-Analysis of Immunosuppression Withdrawal Trials in Renal Transplantation
2000
Delayed graft function in kidney transplantation
2004 Standout
Randomized double-blind study of immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with mycophenolate mofetil-containing triple therapy in renal transplantation12
2003
Hyperthermia in combined treatment of cancer
2002 Standout
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
Echocardiographic Evaluation of Mitral Valve Structure and Function in Patients Followed for at Least 6 Months After Percutaneous Balloon Mitral Valvuloplasty
1988
Infections after Liver Transplantation
1988
Technical Details of Intraoperative Lymphatic Mapping for Early Stage Melanoma
1992 Standout
The Prognostic Implications of Microscopic Satellites in Patients With Clinical Stage I Melanoma
1991
Long-term follow-up of patients undergoing closed transventricular mitral commissurotomy: A useful surrogate for percutaneous balloon mitral valvuloplasty?
1992
Therapy for cutaneous melanoma: An update
1990
Definitions of Cytomegalovirus Infection and Disease in Transplant Recipients
2002 Standout
Tacrolimus
1993
Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells
2010 Standout
The Anti-CD3-Induced Syndrome: A Consequence of Massive In Vivo Cell Activation
1991
Cutaneous melanoma: Prognosis and treatment results worldwide
1992
The Epidemiology of Skin Cancer
1996 Standout
A Comparison of Observational Studies and Randomized, Controlled Trials
2000 Standout
Model Predicting Survival in Stage I Melanoma Based on Tumor Progression
1989 Standout
CD154 Blockade for Induction of Mixed Chimerism and Prolonged Renal Allograft Survival in Nonhuman Primates
2004
Distinct Sets of Genetic Alterations in Melanoma
2005 Standout
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
2004 Standout
Clinical Pharmacokinetics of Tacrolimus
1995 Standout
Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation
1996 Standout
Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials
1995 Standout
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
2017 Standout
Regulatory T cells in transplantation tolerance
2003 StandoutNobel
LONG-TERM OUTCOME AND ALLOANTIBODY PRODUCTION IN A NON-MYELOABLATIVE REGIMEN FOR INDUCTION OF RENAL ALLOGRAFT TOLERANCE1
1999
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
2000 Standout
Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.
1996 Standout
Basiliximab plus low‐dose cyclosporin vs. OKT3 for induction immunosuppression following renal transplantation
2003
Strategies to Improve Long-Term Outcomes after Renal Transplantation
2002 Standout
Costimulation Blockade with Belatacept in Renal Transplantation
2005 Standout
Cutaneous malignant melanoma (arizona cancer center experience). I. Natural history and prognostic factors influencing survival in patients with stage i disease
1988
PLASMA EXCHANGE AND TACROLIMUS-MYCOPHENOLATE RESCUE FOR ACUTE HUMORAL REJECTION IN KIDNEY TRANSPLANTATION1
1998
The Use of Therapeutic Drug Monitoring to Optimise Immunosuppressive Therapy
1996
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Depletion of CD8 Memory T Cells for Induction of Tolerance of a Previously Transplanted Kidney Allograft
2007
HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression
2008 Standout
MODIFICATIONS OF THE CONDITIONING REGIMEN FOR ACHIEVING MIXED CHIMERISM AND DONOR-SPECIFIC TOLERANCE IN CYNOMOLGUS MONKEYS1
1997
The High-Risk Liver Allograft Recipient
1992
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Infection in Organ-Transplant Recipients
1998 Standout
Impact of Cytomegalovirus Infection on Organ Transplant Recipients
1990
Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients
1997
Successful Use of a Physiologically Acceptable Artificial Skin in the Treatment of Extensive Burn Injury
1981 Standout
Immunosuppression and Temporary Skin Transplantation in the Treatment of Massive Third Degree Burns
1975
Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation.
1988
Prediction of successful outcome in 130 patients undergoing percutaneous balloon mitral valvotomy.
1990
Long-term human cytolytic T-cell lines allospecific for HLA-DR6 antigen are OKT4+.
1982
Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathway
2008 StandoutNobel
Open mitral commissurotomy
1980
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain
1986 StandoutNobel
Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4.
1985
Permanent Coverage of Large Burn Wounds with Autologous Cultured Human Epithelium
1984 Standout
Thymus and autoimmunity: capacity of the normal thymus to produce pathogenic self-reactive T cells and conditions required for their induction of autoimmune disease.
1990 StandoutNobel
A Prospective Randomized Study of Regional Extremity Perfusion in Patients with Malignant Melanoma
1984
Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System
2001 Standout
The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobulin gene family
1985 StandoutNobel
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
2023 StandoutNobel
Closed mitral valvotomy: early results and long-term follow-up of 3724 consecutive patients.
1983
Anti-CD3 Therapy Promotes Tolerance by Selectively Depleting Pathogenic Cells while Preserving Regulatory T Cells
2011
A Comparison of Prognostic Factors and Surgical Results in 1,786 Patients with Localized (Stage I) Melanoma Treated in Alabama, USA, and New South Wales, Australia
1982
High Pathogenic Potential of Low-Affinity Autoantibodies in Experimental Autoimmune Hemolytic Anemia
1999 StandoutNobel
T Cell Studies in a Peptide-Induced Model of Systemic Lupus Erythematosus
2001 StandoutNobel
Randomized versus historical controls for clinical trials
1982
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Indications for Cardiac Catheterization and Intervention in Pediatric Cardiac Disease
2011 Standout
Evaluating non-randomised intervention studies
2003 Standout
Cytokine Storm
2020 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Prognostic factors for stagei melanoma of the skin: A review
1985
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma
2001 Standout
REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY
1984 Standout
Permanent coverage of large burn wounds with autologous cultured human epithelium
1985 Standout
Clinical application of transvenous mitral commissurotomy by a new balloon catheter
1984
Prognostic histopathological factors in malignant melanoma
1985
Malignant Melanoma
1981
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
The price of immunotherapy
1981
The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice.
1993
Actuarial Outcome After Catheter Balloon Commissurotomy in Patients With Mitral Stenosis
1997
Cutaneous Malignant Melanoma: Prognostic Guidelines for Physicians and Patients
1982
Works of Cosimi Ab being referenced
Clinical development of Orthoclone OKT3.
1987
Monoclonal antibodies to human T cell subsets: use for immunological monitoring and immunosuppression in renal transplantation.
1982
Prolonged survival of nonhuman primate renal allograft recipients treated only with anti-CD4 monoclonal antibody.
1990
Evaluation in primate renal allograft recipients of monoclonal antibody to human T-cell subclasses.
1981
Update on liver transplantation.
1991
Immunologic monitoring with monoclonal antibodies to human T-cell subsets.
1981
Cytomegalovirus excretion 2-14 years after renal transplantation.
1979
Antithymocyte globulin as the primary treatment for renal allograft rejection.
1983
Experience with large-dose intravenous antithymocyte globulin in primates and man.
1970
Management of the renal allograft recipient: immunosuppressive protocols for long-term success.
1994
Transventricular mitral valvulotomy. Analysis of factors influencing operative and late results.
1974
Procurement of a whole pancreas and liver from the same cadaveric donor.
1989
A prognostic model for clinical stage I melanoma of the lower extremity. Location on foot as independent risk factor for recurrent disease.
1981
Randomized trial of adjuvant therapy for "high risk" primary malignant melanoma.
1978